UBS (CH) Equity Fd Swiss Hi Div CHF I-A1

Performance (in CHF)

Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.

Performance

1 month -6.33%
Current year 2.91%
3 years p.a. 3.94%
5 years p.a. 8.18%
10 years p.a. 7.25%
Since inception p.a. n.a.

Rolling performance in %

Key figures

YTD 1 year 3 years 5 years 10 years
Performance 2.91% 7.21% 12.30% 48.21% 101.40%
Maximum profit on monthly basis 6.00% 6.12% 6.12% 10.52% 10.52%
Maximum loss on monthly basis -1.53% -2.86% -7.47% -7.47% -8.31%
Max drawdown -14.31% -14.31% -16.42% -19.58% -28.94%
Volatility 19.66% 14.43% 13.05% 13.49% 14.36%
Sharpe ratio 0.36 0.35 0.10 0.50 0.47
Maximum continuous profit in months 2 2 5 7 7
Maximum continuous loss in months 1 2 4 4 4
Positive months / profit duration in months 3 7 21 38 74
Negative months / loss duration in months 1 6 16 23 47

Master data

Fund name UBS (CH) Equity Fd Swiss Hi Div CHF I-A1
Fund management company UBS Fund Management (Switzerland) AG
Fund domicile Switzerland
Inception date 09 January 2014
ISIN CH0205552091
Swiss security no. 20555209
Fund currency CHF
Appropriation of income distributing
Issuing commission
Ongoing charges under PRIIP KID as at 16 October 2024 0.64%
End of financial year 31 August
Paying agent UBS Switzerland AG
Fund volume as at 31 March 2025 730.48 Mio. CHF
Net asset value (NAV) as at 23 April 2025 183.93 CHF

Portfolio structure

Top holdings of fund volume (in %)

Nestle 10.09%
Novartis AG 9.88%
Roche Hldg. Genußsch. 9.75%
Zurich Insurance Group 9.20%
UBS Group AG 7.43%
Swiss Re AG 6.66%
ABB Ltd.-Reg. 5.99%
Givaudan 4.40%
Holcim AG 4.27%
Swiss Life 3.47%

Asset allocation

Currency

Countries

Sectors